Celt ACD PLUS Vascular Closure Device 7F CLT-07Recalls & reported problems
Vasorum Limited · Celt ACD PLUS Vascular Closure Device 7F (US) · Class 3 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05391530280679), received between May 22, 2025 and Jun 11, 2025 — classified as 2 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information1
- Malposition of Device1
- Off-Label Use1
Patient problems
- Device Embedded In Tissue or Plaque1
- Insufficient Information1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJun 11, 2025Insufficient Device Problem Information; Insufficient Device Problem Information
A MEDWATCH REPORT FORM WAS RECEIVED WHICH STATED THAT THE 6F CELT ACD CLOSURE DEVICE WAS MAL-DEPLOYED AND INTRALUMINAL IN THE RIGHT COMMON FEMORAL ARTERY. THE MAL-DEPLOYED CLOSURE DEVICE WAS IMMEDIATELY RETRIEVED SUCCESSFULLY. AN UPDATE WAS RECEIVED ON (B)(6) 2025 INFORMING THAT THE EMBOLIZED IMPLANT WAS RETRIEVED SUCCESSFULLY BY A SNARE. ATTEMPTS TO OBTAIN FINAL PATIENT STATUS WERE UNSUCCESSFUL.
Patient problems: Insufficient Information
MAUDE report 22183532 ↗InjuryMay 22, 2025Off-Label Use; Malposition of Device; Off-Label Use; Malposition of Device
IT WAS REPORTED THAT PHYSICIAN USED A 7F CELT ACD PLUS DEVICE TO CLOSE AN 8F ARTERIOTOMY AFTER A 4-HOUR CORONARY CTO PROCEDURE. THE DEVICE WAS RETRACTED TO WHAT WAS THOUGHT TO BE THE ARTERIOTOMY AFTER THE DISTAL WING WAS DEPLOYED. UPON RAISING TO 90 DEGREES THE BLOOD SIGNAL DID NOT COMPLETELY STOP SO PHYSICIAN MADE MULTIPLE ATTEMPTS TO RETRACT FURTHER AND ELEVATE AGAIN. THE BLOOD SIGNAL APPEARED TO STOP. UPON DEPLOYMENT OF THE PROXIMAL WING THE DEVICE APPEARED TO JUMP UPWARD SLIGHTLY. IMPLANT WAS EJECTED, BLEEDING WAS NOTED AND MANUAL COMPRESSION WAS USED TO ACHIEVE HEMOSTASIS FOR APPROXIMATELY 1 HOUR. THE PHYSICIAN ELECTED TO GIVE A BLOOD TRANSFUSION SINCE THE PATIENT WAS BECOMING HYPOTENSIVE, AND THE PATIENT WAS THEN REASSESSED AND AN ATTEMPT TO ACHIEVE HAEMOSTATIC CONTROL WITH AN ANGIOPLASTY BALLOON WAS NOT SUCCESSFUL. PATIENT WAS THEN BROUGHT TO SURGERY TO REPAIR THE ARTERIOTOMY. PATIENT WAS REPORTED TO BE OK AND SURGERY SUCCESSFUL.
Patient problems: Device Embedded In Tissue or Plaque
MAUDE report 22068514 ↗
Other Device, Hemostasis, Vascular devices
- Perclose™ ProStyle™ 12773-03Abbott Vascular Inc. · Device, hemostasis, vascular8 deaths18,037 reports
- Perclose ProGlide™ 12673-03Abbott Vascular Inc. · DEVICE, HEMOSTASIS, VASCULAR13 deaths10,588 reports
- ANGIO-SEAL 610130Terumo Medical Corporation · Device, hemostasis, vascular3 deaths1,651 reports
- MYNXGRIP MX6721Cordis US Corp. · Device, hemostasis, vascular3 deaths1,361 reports
- MYNXGRIP MX5021Cordis US Corp. · Device, hemostasis, vascular2 recalls915 reports
- MANTA 2115Essential Medical, Inc. · Device, Hemostasis, Vascular14 deaths966 reports
- StarClose SE™ 14679-01Abbott Vascular Inc. · DEVICE, HEMOSTASIS, VASCULAR589 reports
- Cordis ExoSeal Vascular Closure Device EX500Cordis US Corp. · DEVICE, HEMOSTASIS, VASCULAR500 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page